A new study found a correlation between the genetic polymorphism of the enzyme methylenetetrahydrofolate reductase and coronary artery disease.
The mechanism of action may be linked to raspberry ellagitannins, study researchers say.
Kaneka also now has exclusive licensing rights to produce and sell AB-Biotics’ products in North America and Japan.
The Council for Responsible Nutrition (Washington, DC) said in a recent press release that 73% of U.S. residents take multivitamins, but these products are not intended to be used as magic bullets in the prevention of serious diseases.
Nutritional Outlook spoke to Scott Steinford, executive director at large of the CoQ10 Association (Salt Lake City, UT), about how trade tensions could negatively affect U.S. and China consumers.
Research has shown that astaxanthin can reduce oxidative stress and inflammation, improve lipid profiles, and promote better blood flow.
Results from the study indicate that a CoQ10 ingredient known commercially as MitoQ may help improve arterial stiffness and “reverse” arterial aging in older adults.
NattoPharma is looking to harness its extensive body of research showing vitamin K2’s heart- and bone-health benefits, as well as establishing clinical biomarkers to demonstrate the consequences of vitamin K2 deficiency, with the hope of one day seeing the creation of a Recommended Daily Intake (RDI) value for K2.
The line is based on the company’s flagship, EPA-rich algae ingredient, Almega PL.
CoQ10 Sports Prototypes Target Athlete Need States, Including Recovery and Immune Health, Says Kaneka
Kaneka showcased new sports prototypes featuring its ubiquinol CoQ10 ingredient combined with other vitamins and minerals, including in vegicap, powder stick, gel, and gelatin capsule formats, at May’s Vitafoods Europe trade show.